# Regeneron Pharmaceuticals id: ent_regeneron-pharmaceuticals wikidata: Q7308054 kind: organization timeline: /timelines/regeneron-pharmaceuticals.md page: /record/regeneron-pharmaceuticals same_as: https://asof.is/record/regeneron-pharmaceuticals (how to cite the id: /identifiers.md) Regeneron Pharmaceuticals is an American pharmaceutical company, headquartered in Tarrytown. Its CEO is Leonard S. Schleifer, since 1988. It reported revenue of $14.34B for the period ended December 31, 2025. ## Key facts - CEO: Leonard S. Schleifer (since 1988) · claim: /claim/clm_31DC6D4DC56C.md - CFO: Christopher Fenimore · claim: /claim/clm_0D057E1B2379.md - Headquarters: Tarrytown · claim: /claim/clm_4EBDB058F389.md - Revenue: $14.34B (to 2025-12-31) [recorded: 14,342,900,000 United States dollar] · claim: /claim/clm_E5421E95D3E6.md - Ticker: REGN · Nasdaq · claim: /claim/clm_CE8DC6176B9E.md ## Questions **Who is the CEO of Regeneron Pharmaceuticals?** Leonard S. Schleifer, since 1988, as the AsOf record states with its sources. **Where is Regeneron Pharmaceuticals headquartered?** Tarrytown. **What is Regeneron Pharmaceuticals's revenue?** $14.34B for the period ended December 31, 2025. ## Fact pages One page per fact: the current value with its sources, then every dated value and what replaced what. Fetch any of them as markdown. - [Regeneron Pharmaceuticals CEO](/record/regeneron-pharmaceuticals/ceo.md) - [Regeneron Pharmaceuticals CFO](/record/regeneron-pharmaceuticals/cfo.md) - [Regeneron Pharmaceuticals headquarters](/record/regeneron-pharmaceuticals/headquarters.md) - [Regeneron Pharmaceuticals revenue](/record/regeneron-pharmaceuticals/revenue.md) - [Regeneron Pharmaceuticals net income](/record/regeneron-pharmaceuticals/net_income.md) - [Regeneron Pharmaceuticals operating income](/record/regeneron-pharmaceuticals/operating_income.md) - [Regeneron Pharmaceuticals quarterly revenue](/record/regeneron-pharmaceuticals/quarterly_revenue.md) ## Current state What the record asserts: claims that held, valid by their sources or primary-sourced at confidence 0.7 or more. Unverified, disputed, retracted and review-marked claims are listed below, labelled, not here. - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | registrant_name | REGENERON PHARMACEUTICALS, INC. | valid 1995-07-26 to present | conf 0.95 | valid | [clm_0230630DE966](/claim/clm_0230630DE966.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | ceo | Leonard S. Schleifer | valid 1988-01-01 to present | conf 0.95 | valid | [clm_31DC6D4DC56C](/claim/clm_31DC6D4DC56C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | headquarters | Tarrytown | valid undated to present | conf 0.95 | valid | [clm_4EBDB058F389](/claim/clm_4EBDB058F389.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 14,342,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,504,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_7514724ED5E9](/claim/clm_7514724ED5E9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 3,577,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_1B456AFB0CC5](/claim/clm_1B456AFB0CC5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 44,405,200,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_F46BE3EF6472](/claim/clm_F46BE3EF6472.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | listed_on | Nasdaq | valid undated to present | conf 0.95 | valid | [clm_60E05C2B8B5C](/claim/clm_60E05C2B8B5C.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,659,100,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_5EBA4C72A92F](/claim/clm_5EBA4C72A92F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cfo | Christopher Fenimore | valid 2024-02-01 to present | conf 0.95 | valid | [clm_0D057E1B2379](/claim/clm_0D057E1B2379.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,948,700,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_DEF587D6916A](/claim/clm_DEF587D6916A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 2,048,200,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_4585DB96888D](/claim/clm_4585DB96888D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,794,700,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_4D8C13296D0A](/claim/clm_4D8C13296D0A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 5,115,800,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_15BDC7B1496E](/claim/clm_15BDC7B1496E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 5,850,200,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_1819F20C7CC4](/claim/clm_1819F20C7CC4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 93,955,110 shares | valid 2012-07-13 to present | conf 0.95 | valid | [clm_24C3500A1DEF](/claim/clm_24C3500A1DEF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 33,498,500,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_24A29A7153C0](/claim/clm_24A29A7153C0.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm ## All claims One claim per line, newest first. Superseded claims stay visible. - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 5,115,800,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_15BDC7B1496E](/claim/clm_15BDC7B1496E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 33,498,500,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_24A29A7153C0](/claim/clm_24A29A7153C0.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 2,048,200,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_4585DB96888D](/claim/clm_4585DB96888D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,794,700,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_4D8C13296D0A](/claim/clm_4D8C13296D0A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,659,100,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_5EBA4C72A92F](/claim/clm_5EBA4C72A92F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,948,700,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_DEF587D6916A](/claim/clm_DEF587D6916A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 44,405,200,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_F46BE3EF6472](/claim/clm_F46BE3EF6472.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 41,730,600,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_F46BE3EF6472](/claim/clm_F46BE3EF6472.md) | [clm_0A911086D51B](/claim/clm_0A911086D51B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 4,290,700,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_15BDC7B1496E](/claim/clm_15BDC7B1496E.md) | [clm_11098E7F99BC](/claim/clm_11098E7F99BC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,631,600,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_4D8C13296D0A](/claim/clm_4D8C13296D0A.md) | [clm_223E08E3A074](/claim/clm_223E08E3A074.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,293,500,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_4585DB96888D](/claim/clm_4585DB96888D.md) | [clm_2721EF4559B5](/claim/clm_2721EF4559B5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,296,900,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_DEF587D6916A](/claim/clm_DEF587D6916A.md) | [clm_6178480D55DF](/claim/clm_6178480D55DF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,455,800,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_5EBA4C72A92F](/claim/clm_5EBA4C72A92F.md) | [clm_6D7C70396974](/claim/clm_6D7C70396974.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 31,711,400,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_24A29A7153C0](/claim/clm_24A29A7153C0.md) | [clm_B9E0E558C863](/claim/clm_B9E0E558C863.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,962,600,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_6D7C70396974](/claim/clm_6D7C70396974.md) | [clm_518E1E5FF285](/claim/clm_518E1E5FF285.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/0000872589-26-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 727,200,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_6178480D55DF](/claim/clm_6178480D55DF.md) | [clm_55728063B1D6](/claim/clm_55728063B1D6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/0000872589-26-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 642,900,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_2721EF4559B5](/claim/clm_2721EF4559B5.md) | [clm_6BF4C3658A74](/claim/clm_6BF4C3658A74.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/0000872589-26-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 40,868,800,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_0A911086D51B](/claim/clm_0A911086D51B.md) | [clm_81C2322B5ECE](/claim/clm_81C2322B5ECE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/0000872589-26-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,605,400,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_11098E7F99BC](/claim/clm_11098E7F99BC.md) | [clm_89291214D4AA](/claim/clm_89291214D4AA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/0000872589-26-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 31,423,600,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_B9E0E558C863](/claim/clm_B9E0E558C863.md) | [clm_98A5851FED3C](/claim/clm_98A5851FED3C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/0000872589-26-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,543,500,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_223E08E3A074](/claim/clm_223E08E3A074.md) | [clm_D76E4D0088C5](/claim/clm_D76E4D0088C5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/0000872589-26-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 5,850,200,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_1819F20C7CC4](/claim/clm_1819F20C7CC4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 3,577,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_1B456AFB0CC5](/claim/clm_1B456AFB0CC5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 31,256,900,000 United States dollar | valid 2025-12-31 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_98A5851FED3C](/claim/clm_98A5851FED3C.md) | [clm_68C522C0BDED](/claim/clm_68C522C0BDED.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,504,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_7514724ED5E9](/claim/clm_7514724ED5E9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,118,100,000 United States dollar | valid 2025-12-31 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_518E1E5FF285](/claim/clm_518E1E5FF285.md) | [clm_B18C1963BC40](/claim/clm_B18C1963BC40.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 40,558,700,000 United States dollar | valid 2025-12-31 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_81C2322B5ECE](/claim/clm_81C2322B5ECE.md) | [clm_CFD74D844717](/claim/clm_CFD74D844717.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 14,342,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,026,800,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_6BF4C3658A74](/claim/clm_6BF4C3658A74.md) | [clm_0F41A2F44A01](/claim/clm_0F41A2F44A01.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,754,300,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_89291214D4AA](/claim/clm_89291214D4AA.md) | [clm_471EC2DBAE0B](/claim/clm_471EC2DBAE0B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,506,400,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_B18C1963BC40](/claim/clm_B18C1963BC40.md) | [clm_5CC511D1F933](/claim/clm_5CC511D1F933.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,460,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_55728063B1D6](/claim/clm_55728063B1D6.md) | [clm_75B9586D5FEE](/claim/clm_75B9586D5FEE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 40,169,400,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_CFD74D844717](/claim/clm_CFD74D844717.md) | [clm_A47C41C5A48C](/claim/clm_A47C41C5A48C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 30,957,800,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_68C522C0BDED](/claim/clm_68C522C0BDED.md) | [clm_CF9BA729AF1E](/claim/clm_CF9BA729AF1E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,475,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_D76E4D0088C5](/claim/clm_D76E4D0088C5.md) | [clm_F00F9DA4362C](/claim/clm_F00F9DA4362C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 38,219,200,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_A47C41C5A48C](/claim/clm_A47C41C5A48C.md) | [clm_0BB82D220F7E](/claim/clm_0BB82D220F7E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000019/0000872589-25-000019-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,079,500,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_0F41A2F44A01](/claim/clm_0F41A2F44A01.md) | [clm_0CA4006DEF0C](/claim/clm_0CA4006DEF0C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000019/0000872589-25-000019-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,995,800,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_5CC511D1F933](/claim/clm_5CC511D1F933.md) | [clm_436CC0AE1280](/claim/clm_436CC0AE1280.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000019/0000872589-25-000019-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,675,600,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_471EC2DBAE0B](/claim/clm_471EC2DBAE0B.md) | [clm_43E679905BB9](/claim/clm_43E679905BB9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000019/0000872589-25-000019-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 29,938,900,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_CF9BA729AF1E](/claim/clm_CF9BA729AF1E.md) | [clm_4D236E01F288](/claim/clm_4D236E01F288.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000019/0000872589-25-000019-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,421,700,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_F00F9DA4362C](/claim/clm_F00F9DA4362C.md) | [clm_7D676D307920](/claim/clm_7D676D307920.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000019/0000872589-25-000019-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,391,600,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_75B9586D5FEE](/claim/clm_75B9586D5FEE.md) | [clm_80007FEE76CE](/claim/clm_80007FEE76CE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000019/0000872589-25-000019-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,028,700,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_43E679905BB9](/claim/clm_43E679905BB9.md) | [clm_04C1A63A27E9](/claim/clm_04C1A63A27E9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 591,700,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_0CA4006DEF0C](/claim/clm_0CA4006DEF0C.md) | [clm_3F78C327F519](/claim/clm_3F78C327F519.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,327,400,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_7D676D307920](/claim/clm_7D676D307920.md) | [clm_4BF4BD70527E](/claim/clm_4BF4BD70527E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 808,700,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_80007FEE76CE](/claim/clm_80007FEE76CE.md) | [clm_65FFF2CBF333](/claim/clm_65FFF2CBF333.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,090,200,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_436CC0AE1280](/claim/clm_436CC0AE1280.md) | [clm_775D46B7A29F](/claim/clm_775D46B7A29F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 29,387,600,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_4D236E01F288](/claim/clm_4D236E01F288.md) | [clm_B1CBF863516B](/claim/clm_B1CBF863516B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 37,545,200,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_0BB82D220F7E](/claim/clm_0BB82D220F7E.md) | [clm_DADAA2FC572E](/claim/clm_DADAA2FC572E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 3,990,700,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_1B456AFB0CC5](/claim/clm_1B456AFB0CC5.md) | [clm_398CD3D76930](/claim/clm_398CD3D76930.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 29,353,600,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_B1CBF863516B](/claim/clm_B1CBF863516B.md) | [clm_3F5BAE27E768](/claim/clm_3F5BAE27E768.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 37,759,400,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_DADAA2FC572E](/claim/clm_DADAA2FC572E.md) | [clm_428AF772B422](/claim/clm_428AF772B422.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,412,600,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_7514724ED5E9](/claim/clm_7514724ED5E9.md) | [clm_4E27594C511A](/claim/clm_4E27594C511A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 5,132,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_1819F20C7CC4](/claim/clm_1819F20C7CC4.md) | [clm_C301E7CAF361](/claim/clm_C301E7CAF361.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 14,202,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md) | [clm_EE95AAD2339E](/claim/clm_EE95AAD2339E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,488,200,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_775D46B7A29F](/claim/clm_775D46B7A29F.md) | [clm_F0F5921A0058](/claim/clm_F0F5921A0058.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 37,441,900,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_428AF772B422](/claim/clm_428AF772B422.md) | [clm_58CF60C9C3BB](/claim/clm_58CF60C9C3BB.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,011,800,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_F0F5921A0058](/claim/clm_F0F5921A0058.md) | [clm_616C3B8DE457](/claim/clm_616C3B8DE457.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,271,500,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_4BF4BD70527E](/claim/clm_4BF4BD70527E.md) | [clm_61BE04D629BB](/claim/clm_61BE04D629BB.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,720,700,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_04C1A63A27E9](/claim/clm_04C1A63A27E9.md) | [clm_A6AD04E866B3](/claim/clm_A6AD04E866B3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,340,600,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_65FFF2CBF333](/claim/clm_65FFF2CBF333.md) | [clm_B2193D668623](/claim/clm_B2193D668623.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,179,500,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_3F78C327F519](/claim/clm_3F78C327F519.md) | [clm_EB508637D538](/claim/clm_EB508637D538.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 29,325,900,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_3F5BAE27E768](/claim/clm_3F5BAE27E768.md) | [clm_F515E2AB009D](/claim/clm_F515E2AB009D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,432,300,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_B2193D668623](/claim/clm_B2193D668623.md) | [clm_01E985023556](/claim/clm_01E985023556.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000028/0001804220-24-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,547,100,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_A6AD04E866B3](/claim/clm_A6AD04E866B3.md) | [clm_3891C0E928C4](/claim/clm_3891C0E928C4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000028/0001804220-24-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 36,086,800,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_58CF60C9C3BB](/claim/clm_58CF60C9C3BB.md) | [clm_567F86365DD5](/claim/clm_567F86365DD5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000028/0001804220-24-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,200,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_61BE04D629BB](/claim/clm_61BE04D629BB.md) | [clm_6410B4B55A22](/claim/clm_6410B4B55A22.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000028/0001804220-24-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,069,600,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_EB508637D538](/claim/clm_EB508637D538.md) | [clm_9B13454F52AA](/claim/clm_9B13454F52AA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000028/0001804220-24-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,920,700,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_616C3B8DE457](/claim/clm_616C3B8DE457.md) | [clm_B12373EE7B0C](/claim/clm_B12373EE7B0C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000028/0001804220-24-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 28,205,800,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_F515E2AB009D](/claim/clm_F515E2AB009D.md) | [clm_E2B4233513FC](/claim/clm_E2B4233513FC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000028/0001804220-24-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 751,400,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_9B13454F52AA](/claim/clm_9B13454F52AA.md) | [clm_5DA47B349189](/claim/clm_5DA47B349189.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 26,991,100,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_E2B4233513FC](/claim/clm_E2B4233513FC.md) | [clm_792E7538AC26](/claim/clm_792E7538AC26.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,248,400,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_6410B4B55A22](/claim/clm_6410B4B55A22.md) | [clm_833AAF046462](/claim/clm_833AAF046462.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 34,369,600,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_567F86365DD5](/claim/clm_567F86365DD5.md) | [clm_89235EAA3408](/claim/clm_89235EAA3408.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,145,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_3891C0E928C4](/claim/clm_3891C0E928C4.md) | [clm_A39660FD9A27](/claim/clm_A39660FD9A27.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,602,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_B12373EE7B0C](/claim/clm_B12373EE7B0C.md) | [clm_BB705899FBD2](/claim/clm_BB705899FBD2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 722,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_01E985023556](/claim/clm_01E985023556.md) | [clm_D6451915A936](/claim/clm_D6451915A936.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cfo | Christopher Fenimore | valid 2024-02-01 to present | conf 0.95 | valid | [clm_0D057E1B2379](/claim/clm_0D057E1B2379.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 13,117,200,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_EE95AAD2339E](/claim/clm_EE95AAD2339E.md) | [clm_0A05777F6B3A](/claim/clm_0A05777F6B3A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 3,953,600,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_4E27594C511A](/claim/clm_4E27594C511A.md) | [clm_11400CA0B8A6](/claim/clm_11400CA0B8A6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 33,080,200,000 United States dollar | valid 2023-12-31 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_89235EAA3408](/claim/clm_89235EAA3408.md) | [clm_24DDC4DBA718](/claim/clm_24DDC4DBA718.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 4,439,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_C301E7CAF361](/claim/clm_C301E7CAF361.md) | [clm_5546754D63D6](/claim/clm_5546754D63D6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 4,047,100,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_398CD3D76930](/claim/clm_398CD3D76930.md) | [clm_5B0035249BB7](/claim/clm_5B0035249BB7.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,730,000,000 United States dollar | valid 2023-12-31 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_BB705899FBD2](/claim/clm_BB705899FBD2.md) | [clm_65E6ADFD0D80](/claim/clm_65E6ADFD0D80.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 25,973,100,000 United States dollar | valid 2023-12-31 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_792E7538AC26](/claim/clm_792E7538AC26.md) | [clm_FF328F070B8B](/claim/clm_FF328F070B8B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,007,800,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_D6451915A936](/claim/clm_D6451915A936.md) | [clm_0089CAC97396](/claim/clm_0089CAC97396.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 24,904,400,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_FF328F070B8B](/claim/clm_FF328F070B8B.md) | [clm_426EFFDCB275](/claim/clm_426EFFDCB275.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,075,300,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_833AAF046462](/claim/clm_833AAF046462.md) | [clm_5C3B864B89C2](/claim/clm_5C3B864B89C2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 32,163,300,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_24DDC4DBA718](/claim/clm_24DDC4DBA718.md) | [clm_924A6CAD98A4](/claim/clm_924A6CAD98A4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,362,700,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_A39660FD9A27](/claim/clm_A39660FD9A27.md) | [clm_D14890ED012F](/claim/clm_D14890ED012F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,111,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_5DA47B349189](/claim/clm_5DA47B349189.md) | [clm_D79F18FC7528](/claim/clm_D79F18FC7528.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,152,300,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_65E6ADFD0D80](/claim/clm_65E6ADFD0D80.md) | [clm_FD93D07E05CD](/claim/clm_FD93D07E05CD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,158,100,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_D14890ED012F](/claim/clm_D14890ED012F.md) | [clm_03FC6245728F](/claim/clm_03FC6245728F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 968,400,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_0089CAC97396](/claim/clm_0089CAC97396.md) | [clm_0598850A1A59](/claim/clm_0598850A1A59.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,016,500,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_D79F18FC7528](/claim/clm_D79F18FC7528.md) | [clm_0742E18258B7](/claim/clm_0742E18258B7.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 30,657,500,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_924A6CAD98A4](/claim/clm_924A6CAD98A4.md) | [clm_4CC63E98652A](/claim/clm_4CC63E98652A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,085,300,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_5C3B864B89C2](/claim/clm_5C3B864B89C2.md) | [clm_7BB6A57A5F50](/claim/clm_7BB6A57A5F50.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 24,017,900,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_426EFFDCB275](/claim/clm_426EFFDCB275.md) | [clm_C2064E6D19CF](/claim/clm_C2064E6D19CF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,937,200,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_FD93D07E05CD](/claim/clm_FD93D07E05CD.md) | [clm_F903F28AA80F](/claim/clm_F903F28AA80F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 30,059,900,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_4CC63E98652A](/claim/clm_4CC63E98652A.md) | [clm_0963A3E9D139](/claim/clm_0963A3E9D139.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,162,100,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_03FC6245728F](/claim/clm_03FC6245728F.md) | [clm_179FAEBC31F3](/claim/clm_179FAEBC31F3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,101,200,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_7BB6A57A5F50](/claim/clm_7BB6A57A5F50.md) | [clm_7DFE5AEE2C50](/claim/clm_7DFE5AEE2C50.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,916,300,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_F903F28AA80F](/claim/clm_F903F28AA80F.md) | [clm_7E7BB784381A](/claim/clm_7E7BB784381A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 817,800,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_0598850A1A59](/claim/clm_0598850A1A59.md) | [clm_802196BED548](/claim/clm_802196BED548.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 946,700,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_0742E18258B7](/claim/clm_0742E18258B7.md) | [clm_D8EB51091FB4](/claim/clm_D8EB51091FB4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 23,495,200,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_C2064E6D19CF](/claim/clm_C2064E6D19CF.md) | [clm_E4AE0A080B44](/claim/clm_E4AE0A080B44.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 4,738,900,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_5B0035249BB7](/claim/clm_5B0035249BB7.md) | [clm_1DC3E40C4DC4](/claim/clm_1DC3E40C4DC4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/0001804220-23-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,338,400,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_11400CA0B8A6](/claim/clm_11400CA0B8A6.md) | [clm_2FCCACC23EDE](/claim/clm_2FCCACC23EDE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/0001804220-23-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,105,900,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_7E7BB784381A](/claim/clm_7E7BB784381A.md) | [clm_62434FDD6FF4](/claim/clm_62434FDD6FF4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/0001804220-23-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 12,172,900,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_0A05777F6B3A](/claim/clm_0A05777F6B3A.md) | [clm_6E857BE187DF](/claim/clm_6E857BE187DF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/0001804220-23-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 3,592,500,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_5546754D63D6](/claim/clm_5546754D63D6.md) | [clm_80493D8A003C](/claim/clm_80493D8A003C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/0001804220-23-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 22,664,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_E4AE0A080B44](/claim/clm_E4AE0A080B44.md) | [clm_859C44BF3D2E](/claim/clm_859C44BF3D2E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/0001804220-23-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 29,214,500,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_0963A3E9D139](/claim/clm_0963A3E9D139.md) | [clm_A6FC9F35DA9A](/claim/clm_A6FC9F35DA9A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/0001804220-23-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,491,300,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_62434FDD6FF4](/claim/clm_62434FDD6FF4.md) | [clm_018DAD07A3D9](/claim/clm_018DAD07A3D9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000031/0001804220-22-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,315,700,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_802196BED548](/claim/clm_802196BED548.md) | [clm_165D233486E7](/claim/clm_165D233486E7.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000031/0001804220-22-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 21,438,800,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_859C44BF3D2E](/claim/clm_859C44BF3D2E.md) | [clm_3798FEF555E2](/claim/clm_3798FEF555E2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000031/0001804220-22-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 2,936,200,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_179FAEBC31F3](/claim/clm_179FAEBC31F3.md) | [clm_41EB8CF3FDDA](/claim/clm_41EB8CF3FDDA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000031/0001804220-22-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 911,300,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_7DFE5AEE2C50](/claim/clm_7DFE5AEE2C50.md) | [clm_59B0EE58F0CA](/claim/clm_59B0EE58F0CA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000031/0001804220-22-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,223,700,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_D8EB51091FB4](/claim/clm_D8EB51091FB4.md) | [clm_667CCF40E6E7](/claim/clm_667CCF40E6E7.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000031/0001804220-22-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 27,677,800,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_A6FC9F35DA9A](/claim/clm_A6FC9F35DA9A.md) | [clm_8BDAA49A5644](/claim/clm_8BDAA49A5644.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000031/0001804220-22-000031-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 20,687,800,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_3798FEF555E2](/claim/clm_3798FEF555E2.md) | [clm_5C8D7A0356F3](/claim/clm_5C8D7A0356F3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000023/0001804220-22-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,395,100,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_018DAD07A3D9](/claim/clm_018DAD07A3D9.md) | [clm_697E428F102E](/claim/clm_697E428F102E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000023/0001804220-22-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 2,857,200,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_41EB8CF3FDDA](/claim/clm_41EB8CF3FDDA.md) | [clm_704A9CC6C45D](/claim/clm_704A9CC6C45D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000023/0001804220-22-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 27,205,800,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_8BDAA49A5644](/claim/clm_8BDAA49A5644.md) | [clm_AA7919F3BECF](/claim/clm_AA7919F3BECF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000023/0001804220-22-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 852,100,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_165D233486E7](/claim/clm_165D233486E7.md) | [clm_B9D9CE7C44B8](/claim/clm_B9D9CE7C44B8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000023/0001804220-22-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,109,900,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_667CCF40E6E7](/claim/clm_667CCF40E6E7.md) | [clm_C525B24D421A](/claim/clm_C525B24D421A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000023/0001804220-22-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 794,300,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_59B0EE58F0CA](/claim/clm_59B0EE58F0CA.md) | [clm_DC9A1606D340](/claim/clm_DC9A1606D340.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000023/0001804220-22-000023-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 19,914,700,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_5C8D7A0356F3](/claim/clm_5C8D7A0356F3.md) | [clm_1515428319F6](/claim/clm_1515428319F6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,345,700,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_697E428F102E](/claim/clm_697E428F102E.md) | [clm_376D9CFEB579](/claim/clm_376D9CFEB579.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 973,500,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_B9D9CE7C44B8](/claim/clm_B9D9CE7C44B8.md) | [clm_41984D40F359](/claim/clm_41984D40F359.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 843,800,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_DC9A1606D340](/claim/clm_DC9A1606D340.md) | [clm_55A89BC77171](/claim/clm_55A89BC77171.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 26,348,700,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_AA7919F3BECF](/claim/clm_AA7919F3BECF.md) | [clm_723458921D36](/claim/clm_723458921D36.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,258,500,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_C525B24D421A](/claim/clm_C525B24D421A.md) | [clm_8A11620CC590](/claim/clm_8A11620CC590.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 2,965,100,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_704A9CC6C45D](/claim/clm_704A9CC6C45D.md) | [clm_DA35C89878EA](/claim/clm_DA35C89878EA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 18,768,800,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_1515428319F6](/claim/clm_1515428319F6.md) | [clm_193A31C30AA8](/claim/clm_193A31C30AA8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/0001804220-22-000007-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,885,600,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_376D9CFEB579](/claim/clm_376D9CFEB579.md) | [clm_36EE1EF9B7BE](/claim/clm_36EE1EF9B7BE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/0001804220-22-000007-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 2,908,100,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_80493D8A003C](/claim/clm_80493D8A003C.md) | [clm_49AC730473CC](/claim/clm_49AC730473CC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/0001804220-22-000007-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 25,434,800,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_723458921D36](/claim/clm_723458921D36.md) | [clm_90E01C153E99](/claim/clm_90E01C153E99.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/0001804220-22-000007-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 16,071,700,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_6E857BE187DF](/claim/clm_6E857BE187DF.md) | [clm_99583435A585](/claim/clm_99583435A585.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/0001804220-22-000007-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 8,946,800,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_1DC3E40C4DC4](/claim/clm_1DC3E40C4DC4.md) | [clm_C2D9EB28F08E](/claim/clm_C2D9EB28F08E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/0001804220-22-000007-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 8,075,300,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_2FCCACC23EDE](/claim/clm_2FCCACC23EDE.md) | [clm_D26172E0F6F8](/claim/clm_D26172E0F6F8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/0001804220-22-000007-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,632,200,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_41984D40F359](/claim/clm_41984D40F359.md) | [clm_0F99CB02E0F4](/claim/clm_0F99CB02E0F4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000033/0001804220-21-000033-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,847,200,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_8A11620CC590](/claim/clm_8A11620CC590.md) | [clm_71265B6402D6](/claim/clm_71265B6402D6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000033/0001804220-21-000033-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 23,671,500,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_90E01C153E99](/claim/clm_90E01C153E99.md) | [clm_75F778627304](/claim/clm_75F778627304.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000033/0001804220-21-000033-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 17,258,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_193A31C30AA8](/claim/clm_193A31C30AA8.md) | [clm_9723C6E3E8CC](/claim/clm_9723C6E3E8CC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000033/0001804220-21-000033-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 665,400,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_55A89BC77171](/claim/clm_55A89BC77171.md) | [clm_D602B5B0E5C5](/claim/clm_D602B5B0E5C5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000033/0001804220-21-000033-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,432,400,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_36EE1EF9B7BE](/claim/clm_36EE1EF9B7BE.md) | [clm_F8115487CBB7](/claim/clm_F8115487CBB7.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000033/0001804220-21-000033-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,452,800,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_DA35C89878EA](/claim/clm_DA35C89878EA.md) | [clm_FC7E3BF6DC06](/claim/clm_FC7E3BF6DC06.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000033/0001804220-21-000033-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 21,485,900,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_75F778627304](/claim/clm_75F778627304.md) | [clm_17B10E4A6B92](/claim/clm_17B10E4A6B92.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 15,127,300,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_9723C6E3E8CC](/claim/clm_9723C6E3E8CC.md) | [clm_3AF93363CB9B](/claim/clm_3AF93363CB9B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 3,098,900,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_0F99CB02E0F4](/claim/clm_0F99CB02E0F4.md) | [clm_584F4235D169](/claim/clm_584F4235D169.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 714,200,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_D602B5B0E5C5](/claim/clm_D602B5B0E5C5.md) | [clm_983BBC03A998](/claim/clm_983BBC03A998.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,072,200,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_F8115487CBB7](/claim/clm_F8115487CBB7.md) | [clm_C7438CFA174A](/claim/clm_C7438CFA174A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 5,138,500,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_FC7E3BF6DC06](/claim/clm_FC7E3BF6DC06.md) | [clm_CBD2A7149F84](/claim/clm_CBD2A7149F84.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 3,347,200,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_71265B6402D6](/claim/clm_71265B6402D6.md) | [clm_F95FA506C1D9](/claim/clm_F95FA506C1D9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,437,900,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_C7438CFA174A](/claim/clm_C7438CFA174A.md) | [clm_2315D6C49C3A](/claim/clm_2315D6C49C3A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 17,772,200,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_17B10E4A6B92](/claim/clm_17B10E4A6B92.md) | [clm_2CFC5ECC25A5](/claim/clm_2CFC5ECC25A5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 742,900,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_983BBC03A998](/claim/clm_983BBC03A998.md) | [clm_4272E4D045DC](/claim/clm_4272E4D045DC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 11,977,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_3AF93363CB9B](/claim/clm_3AF93363CB9B.md) | [clm_51B4B52D2498](/claim/clm_51B4B52D2498.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,112,700,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_F95FA506C1D9](/claim/clm_F95FA506C1D9.md) | [clm_6CF3EC7239A5](/claim/clm_6CF3EC7239A5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 2,528,700,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_CBD2A7149F84](/claim/clm_CBD2A7149F84.md) | [clm_9488B81B5C8C](/claim/clm_9488B81B5C8C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,115,200,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_584F4235D169](/claim/clm_584F4235D169.md) | [clm_C9912D8698CC](/claim/clm_C9912D8698CC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 3,513,200,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_D26172E0F6F8](/claim/clm_D26172E0F6F8.md) | [clm_0AB6F3A48383](/claim/clm_0AB6F3A48383.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 11,025,300,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_51B4B52D2498](/claim/clm_51B4B52D2498.md) | [clm_155A4F299072](/claim/clm_155A4F299072.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 2,735,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_49AC730473CC](/claim/clm_49AC730473CC.md) | [clm_55C14CEED321](/claim/clm_55C14CEED321.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 17,163,300,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_2CFC5ECC25A5](/claim/clm_2CFC5ECC25A5.md) | [clm_6964829D3216](/claim/clm_6964829D3216.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 8,497,100,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_99583435A585](/claim/clm_99583435A585.md) | [clm_9C8093C9515A](/claim/clm_9C8093C9515A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 3,576,600,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_C2D9EB28F08E](/claim/clm_C2D9EB28F08E.md) | [clm_B1B09D53441E](/claim/clm_B1B09D53441E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,193,700,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_2315D6C49C3A](/claim/clm_2315D6C49C3A.md) | [clm_DC54DFD6D27B](/claim/clm_DC54DFD6D27B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,573,000,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_DC54DFD6D27B](/claim/clm_DC54DFD6D27B.md) | [clm_0151EA6FB45E](/claim/clm_0151EA6FB45E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 10,125,500,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_155A4F299072](/claim/clm_155A4F299072.md) | [clm_3A63F9598C82](/claim/clm_3A63F9598C82.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 16,084,000,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_6964829D3216](/claim/clm_6964829D3216.md) | [clm_8D47F8B72C13](/claim/clm_8D47F8B72C13.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 684,600,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_4272E4D045DC](/claim/clm_4272E4D045DC.md) | [clm_A4EE4D07A0E8](/claim/clm_A4EE4D07A0E8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 2,294,000,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_9488B81B5C8C](/claim/clm_9488B81B5C8C.md) | [clm_E888336416D4](/claim/clm_E888336416D4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 842,100,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_C9912D8698CC](/claim/clm_C9912D8698CC.md) | [clm_EB2A23BDB86D](/claim/clm_EB2A23BDB86D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,053,100,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_6CF3EC7239A5](/claim/clm_6CF3EC7239A5.md) | [clm_EF16715A0E38](/claim/clm_EF16715A0E38.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 9,057,400,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_3A63F9598C82](/claim/clm_3A63F9598C82.md) | [clm_2CC38605C128](/claim/clm_2CC38605C128.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000022/0001804220-20-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,992,200,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_0151EA6FB45E](/claim/clm_0151EA6FB45E.md) | [clm_38840DD0F1A6](/claim/clm_38840DD0F1A6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000022/0001804220-20-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 14,428,700,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_8D47F8B72C13](/claim/clm_8D47F8B72C13.md) | [clm_644D82754410](/claim/clm_644D82754410.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000022/0001804220-20-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 897,300,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_EB2A23BDB86D](/claim/clm_EB2A23BDB86D.md) | [clm_A816A2A4556B](/claim/clm_A816A2A4556B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000022/0001804220-20-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,952,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_E888336416D4](/claim/clm_E888336416D4.md) | [clm_B16B9D90B428](/claim/clm_B16B9D90B428.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000022/0001804220-20-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 656,400,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_EF16715A0E38](/claim/clm_EF16715A0E38.md) | [clm_C3A6CADA4F04](/claim/clm_C3A6CADA4F04.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000022/0001804220-20-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 722,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_A4EE4D07A0E8](/claim/clm_A4EE4D07A0E8.md) | [clm_E051418D4ABD](/claim/clm_E051418D4ABD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000022/0001804220-20-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,828,200,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_B16B9D90B428](/claim/clm_B16B9D90B428.md) | [clm_0BEF5E393370](/claim/clm_0BEF5E393370.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000011/0001804220-20-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 15,757,500,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_644D82754410](/claim/clm_644D82754410.md) | [clm_1526DF06387A](/claim/clm_1526DF06387A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000011/0001804220-20-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,208,200,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_38840DD0F1A6](/claim/clm_38840DD0F1A6.md) | [clm_31B1EF0C9CA5](/claim/clm_31B1EF0C9CA5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000011/0001804220-20-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 583,900,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_E051418D4ABD](/claim/clm_E051418D4ABD.md) | [clm_4E4440D647F0](/claim/clm_4E4440D647F0.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000011/0001804220-20-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 624,600,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_A816A2A4556B](/claim/clm_A816A2A4556B.md) | [clm_61AB4AC8223A](/claim/clm_61AB4AC8223A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000011/0001804220-20-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 700,100,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_C3A6CADA4F04](/claim/clm_C3A6CADA4F04.md) | [clm_D51C41802591](/claim/clm_D51C41802591.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000011/0001804220-20-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 12,133,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_2CC38605C128](/claim/clm_2CC38605C128.md) | [clm_FFF6E94E2B98](/claim/clm_FFF6E94E2B98.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422020000011/0001804220-20-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 2,209,800,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_B1B09D53441E](/claim/clm_B1B09D53441E.md) | [clm_1E47F3A48E8B](/claim/clm_1E47F3A48E8B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 2,115,800,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_0AB6F3A48383](/claim/clm_0AB6F3A48383.md) | [clm_272E08FDAC9C](/claim/clm_272E08FDAC9C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 11,089,700,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_FFF6E94E2B98](/claim/clm_FFF6E94E2B98.md) | [clm_32CFF858652E](/claim/clm_32CFF858652E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 3,036,600,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_55C14CEED321](/claim/clm_55C14CEED321.md) | [clm_45C96BE1D685](/claim/clm_45C96BE1D685.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 7,863,400,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_9C8093C9515A](/claim/clm_9C8093C9515A.md) | [clm_98C359CB4FBA](/claim/clm_98C359CB4FBA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 14,805,200,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_1526DF06387A](/claim/clm_1526DF06387A.md) | [clm_A8B1190C6433](/claim/clm_A8B1190C6433.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,617,800,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_31B1EF0C9CA5](/claim/clm_31B1EF0C9CA5.md) | [clm_B770510DD1DE](/claim/clm_B770510DD1DE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 738,500,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_D51C41802591](/claim/clm_D51C41802591.md) | [clm_0355C334B021](/claim/clm_0355C334B021.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 10,504,400,000 United States dollar | valid 2019-09-30 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_32CFF858652E](/claim/clm_32CFF858652E.md) | [clm_0B7B84608335](/claim/clm_0B7B84608335.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 669,600,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_61AB4AC8223A](/claim/clm_61AB4AC8223A.md) | [clm_1FB3AA7D1659](/claim/clm_1FB3AA7D1659.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,384,800,000 United States dollar | valid 2019-09-30 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_B770510DD1DE](/claim/clm_B770510DD1DE.md) | [clm_73EBCD32CE58](/claim/clm_73EBCD32CE58.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 663,400,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_4E4440D647F0](/claim/clm_4E4440D647F0.md) | [clm_9A19CD3DE19C](/claim/clm_9A19CD3DE19C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 13,939,300,000 United States dollar | valid 2019-09-30 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_A8B1190C6433](/claim/clm_A8B1190C6433.md) | [clm_BDCB60E4D48C](/claim/clm_BDCB60E4D48C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 2,048,400,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_0BEF5E393370](/claim/clm_0BEF5E393370.md) | [clm_F3847C54AA19](/claim/clm_F3847C54AA19.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 13,173,600,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_BDCB60E4D48C](/claim/clm_BDCB60E4D48C.md) | [clm_1663DBFF8E0F](/claim/clm_1663DBFF8E0F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000026/0001532176-19-000026-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,048,300,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_9A19CD3DE19C](/claim/clm_9A19CD3DE19C.md) | [clm_1EB9C85348DD](/claim/clm_1EB9C85348DD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000026/0001532176-19-000026-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,045,500,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_73EBCD32CE58](/claim/clm_73EBCD32CE58.md) | [clm_81A51A91E316](/claim/clm_81A51A91E316.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000026/0001532176-19-000026-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 193,100,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_1FB3AA7D1659](/claim/clm_1FB3AA7D1659.md) | [clm_9FCE1A38D2F3](/claim/clm_9FCE1A38D2F3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000026/0001532176-19-000026-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 315,600,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_0355C334B021](/claim/clm_0355C334B021.md) | [clm_A67CDBAE0DFB](/claim/clm_A67CDBAE0DFB.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000026/0001532176-19-000026-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 9,755,900,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_0B7B84608335](/claim/clm_0B7B84608335.md) | [clm_A9EA52B10DF1](/claim/clm_A9EA52B10DF1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000026/0001532176-19-000026-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,933,700,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_F3847C54AA19](/claim/clm_F3847C54AA19.md) | [clm_D84F29A094C8](/claim/clm_D84F29A094C8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000026/0001532176-19-000026-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 12,854,800,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_1663DBFF8E0F](/claim/clm_1663DBFF8E0F.md) | [clm_11C939138FE3](/claim/clm_11C939138FE3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000017/0001532176-19-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,711,800,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_D84F29A094C8](/claim/clm_D84F29A094C8.md) | [clm_47864C915D20](/claim/clm_47864C915D20.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000017/0001532176-19-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,708,500,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_81A51A91E316](/claim/clm_81A51A91E316.md) | [clm_B732DAD499F6](/claim/clm_B732DAD499F6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000017/0001532176-19-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 461,100,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_9FCE1A38D2F3](/claim/clm_9FCE1A38D2F3.md) | [clm_BD7F43D94B6B](/claim/clm_BD7F43D94B6B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000017/0001532176-19-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 480,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_A67CDBAE0DFB](/claim/clm_A67CDBAE0DFB.md) | [clm_D84361499AD2](/claim/clm_D84361499AD2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000017/0001532176-19-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 9,444,700,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_A9EA52B10DF1](/claim/clm_A9EA52B10DF1.md) | [clm_EA1240C78E2F](/claim/clm_EA1240C78E2F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000017/0001532176-19-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 641,800,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_1EB9C85348DD](/claim/clm_1EB9C85348DD.md) | [clm_EB7DE0743EFE](/claim/clm_EB7DE0743EFE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000017/0001532176-19-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 6,710,800,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_98C359CB4FBA](/claim/clm_98C359CB4FBA.md) | [clm_002F725B2106](/claim/clm_002F725B2106.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 2,186,100,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_45C96BE1D685](/claim/clm_45C96BE1D685.md) | [clm_266453DBFA15](/claim/clm_266453DBFA15.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 8,757,300,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_EA1240C78E2F](/claim/clm_EA1240C78E2F.md) | [clm_5D32FAC7392D](/claim/clm_5D32FAC7392D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 11,734,500,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_11C939138FE3](/claim/clm_11C939138FE3.md) | [clm_B7C53A5B665E](/claim/clm_B7C53A5B665E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 2,534,400,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_1E47F3A48E8B](/claim/clm_1E47F3A48E8B.md) | [clm_B9BD4A691253](/claim/clm_B9BD4A691253.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,467,700,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_B732DAD499F6](/claim/clm_B732DAD499F6.md) | [clm_DA2FDFFFBAB2](/claim/clm_DA2FDFFFBAB2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 2,444,400,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_272E08FDAC9C](/claim/clm_272E08FDAC9C.md) | [clm_FCBDA03CE99C](/claim/clm_FCBDA03CE99C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 626,923,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_D84361499AD2](/claim/clm_D84361499AD2.md) | [clm_56C5E89651F4](/claim/clm_56C5E89651F4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000036/0001532176-18-000036-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 594,655,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_BD7F43D94B6B](/claim/clm_BD7F43D94B6B.md) | [clm_5878C421FA89](/claim/clm_5878C421FA89.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000036/0001532176-18-000036-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 10,805,613,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_B7C53A5B665E](/claim/clm_B7C53A5B665E.md) | [clm_598EFC61CEA9](/claim/clm_598EFC61CEA9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000036/0001532176-18-000036-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,663,496,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_47864C915D20](/claim/clm_47864C915D20.md) | [clm_747F97C3BEDC](/claim/clm_747F97C3BEDC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000036/0001532176-18-000036-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 7,868,300,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_5D32FAC7392D](/claim/clm_5D32FAC7392D.md) | [clm_A1DD99D38B48](/claim/clm_A1DD99D38B48.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000036/0001532176-18-000036-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 556,972,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_EB7DE0743EFE](/claim/clm_EB7DE0743EFE.md) | [clm_B522A588AB4A](/claim/clm_B522A588AB4A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000036/0001532176-18-000036-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,087,843,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_DA2FDFFFBAB2](/claim/clm_DA2FDFFFBAB2.md) | [clm_F025AB0020A5](/claim/clm_F025AB0020A5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000036/0001532176-18-000036-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 7,186,426,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_A1DD99D38B48](/claim/clm_A1DD99D38B48.md) | [clm_23FD05B1D458](/claim/clm_23FD05B1D458.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000028/0001532176-18-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,608,022,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_747F97C3BEDC](/claim/clm_747F97C3BEDC.md) | [clm_31D8E26EE368](/claim/clm_31D8E26EE368.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000028/0001532176-18-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 551,412,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_5878C421FA89](/claim/clm_5878C421FA89.md) | [clm_3E424C4A1EAC](/claim/clm_3E424C4A1EAC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000028/0001532176-18-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 917,876,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_F025AB0020A5](/claim/clm_F025AB0020A5.md) | [clm_4718E4C5B45C](/claim/clm_4718E4C5B45C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000028/0001532176-18-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 622,188,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_56C5E89651F4](/claim/clm_56C5E89651F4.md) | [clm_932289F9A641](/claim/clm_932289F9A641.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000028/0001532176-18-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 529,289,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_B522A588AB4A](/claim/clm_B522A588AB4A.md) | [clm_A105D8C47C87](/claim/clm_A105D8C47C87.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000028/0001532176-18-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 9,951,980,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_598EFC61CEA9](/claim/clm_598EFC61CEA9.md) | [clm_C84D8DF1209C](/claim/clm_C84D8DF1209C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000028/0001532176-18-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 498,586,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_A105D8C47C87](/claim/clm_A105D8C47C87.md) | [clm_4BE823A99904](/claim/clm_4BE823A99904.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,511,485,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_31D8E26EE368](/claim/clm_31D8E26EE368.md) | [clm_7E235362DFEC](/claim/clm_7E235362DFEC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 477,980,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_3E424C4A1EAC](/claim/clm_3E424C4A1EAC.md) | [clm_8ABE9095142D](/claim/clm_8ABE9095142D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 567,231,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_932289F9A641](/claim/clm_932289F9A641.md) | [clm_8FA9C48DB5EF](/claim/clm_8FA9C48DB5EF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 6,567,644,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_23FD05B1D458](/claim/clm_23FD05B1D458.md) | [clm_A1D158DEA4C8](/claim/clm_A1D158DEA4C8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,019,491,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_4718E4C5B45C](/claim/clm_4718E4C5B45C.md) | [clm_D7FA3AE5790E](/claim/clm_D7FA3AE5790E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 9,372,696,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_C84D8DF1209C](/claim/clm_C84D8DF1209C.md) | [clm_E21934E189C3](/claim/clm_E21934E189C3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 5,872,227,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_002F725B2106](/claim/clm_002F725B2106.md) | [clm_246434942F91](/claim/clm_246434942F91.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 2,075,142,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_266453DBFA15](/claim/clm_266453DBFA15.md) | [clm_26FF10B62963](/claim/clm_26FF10B62963.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 6,144,078,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_A1D158DEA4C8](/claim/clm_A1D158DEA4C8.md) | [clm_5918225890D8](/claim/clm_5918225890D8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 2,079,591,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_B9BD4A691253](/claim/clm_B9BD4A691253.md) | [clm_C3B4B1FC7983](/claim/clm_C3B4B1FC7983.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 1,198,511,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_FCBDA03CE99C](/claim/clm_FCBDA03CE99C.md) | [clm_DC0177CB2929](/claim/clm_DC0177CB2929.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 8,764,286,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_E21934E189C3](/claim/clm_E21934E189C3.md) | [clm_E5F3BEB8DB99](/claim/clm_E5F3BEB8DB99.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 812,733,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_D7FA3AE5790E](/claim/clm_D7FA3AE5790E.md) | [clm_E98C18EDD84F](/claim/clm_E98C18EDD84F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 559,926,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_8FA9C48DB5EF](/claim/clm_8FA9C48DB5EF.md) | [clm_0068759D81FA](/claim/clm_0068759D81FA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000034/0001532176-17-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,500,673,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_7E235362DFEC](/claim/clm_7E235362DFEC.md) | [clm_13C3FB7E9C67](/claim/clm_13C3FB7E9C67.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000034/0001532176-17-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 8,701,215,000 United States dollar | valid 2017-09-30 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_E5F3BEB8DB99](/claim/clm_E5F3BEB8DB99.md) | [clm_492409E212E4](/claim/clm_492409E212E4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000034/0001532176-17-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 792,065,000 United States dollar | valid 2017-09-30 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_E98C18EDD84F](/claim/clm_E98C18EDD84F.md) | [clm_8AF6FE5A4F7D](/claim/clm_8AF6FE5A4F7D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000034/0001532176-17-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 529,749,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_4BE823A99904](/claim/clm_4BE823A99904.md) | [clm_A9BE529B3D7A](/claim/clm_A9BE529B3D7A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000034/0001532176-17-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 6,051,593,000 United States dollar | valid 2017-09-30 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_5918225890D8](/claim/clm_5918225890D8.md) | [clm_DD3546A9D128](/claim/clm_DD3546A9D128.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000034/0001532176-17-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 388,317,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_8ABE9095142D](/claim/clm_8ABE9095142D.md) | [clm_EE7D9E55E7D2](/claim/clm_EE7D9E55E7D2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000034/0001532176-17-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 744,313,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_8AF6FE5A4F7D](/claim/clm_8AF6FE5A4F7D.md) | [clm_0922596878B8](/claim/clm_0922596878B8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 550,312,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_0068759D81FA](/claim/clm_0068759D81FA.md) | [clm_3C35AE6BEE76](/claim/clm_3C35AE6BEE76.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 5,520,738,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_DD3546A9D128](/claim/clm_DD3546A9D128.md) | [clm_A552A047999A](/claim/clm_A552A047999A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 8,106,373,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_492409E212E4](/claim/clm_492409E212E4.md) | [clm_A8323F1BC4B3](/claim/clm_A8323F1BC4B3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,470,116,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_13C3FB7E9C67](/claim/clm_13C3FB7E9C67.md) | [clm_E83335CDCC26](/claim/clm_E83335CDCC26.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 509,975,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_A9BE529B3D7A](/claim/clm_A9BE529B3D7A.md) | [clm_F6A5C3C217BB](/claim/clm_F6A5C3C217BB.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 387,744,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_EE7D9E55E7D2](/claim/clm_EE7D9E55E7D2.md) | [clm_FDD921AB38B0](/claim/clm_FDD921AB38B0.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000027/0001532176-17-000027-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 430,542,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_3C35AE6BEE76](/claim/clm_3C35AE6BEE76.md) | [clm_0981CA086973](/claim/clm_0981CA086973.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 507,435,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_F6A5C3C217BB](/claim/clm_F6A5C3C217BB.md) | [clm_47AF0CE8CA36](/claim/clm_47AF0CE8CA36.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,318,991,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_E83335CDCC26](/claim/clm_E83335CDCC26.md) | [clm_5AF2197029A2](/claim/clm_5AF2197029A2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 4,866,021,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_A552A047999A](/claim/clm_A552A047999A.md) | [clm_7D612B392881](/claim/clm_7D612B392881.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 7,817,365,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_A8323F1BC4B3](/claim/clm_A8323F1BC4B3.md) | [clm_9994303F1EB2](/claim/clm_9994303F1EB2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 248,931,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_FDD921AB38B0](/claim/clm_FDD921AB38B0.md) | [clm_9B839ECAF179](/claim/clm_9B839ECAF179.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 811,773,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_0922596878B8](/claim/clm_0922596878B8.md) | [clm_FA2D5FA2C813](/claim/clm_FA2D5FA2C813.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 535,203,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_FA2D5FA2C813](/claim/clm_FA2D5FA2C813.md) | [clm_06AB5E3637AD](/claim/clm_06AB5E3637AD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 2,052,295,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_26FF10B62963](/claim/clm_26FF10B62963.md) | [clm_0710977E9941](/claim/clm_0710977E9941.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 1,330,741,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_C3B4B1FC7983](/claim/clm_C3B4B1FC7983.md) | [clm_1B4689E225C8](/claim/clm_1B4689E225C8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 6,973,466,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_9994303F1EB2](/claim/clm_9994303F1EB2.md) | [clm_203164BC0145](/claim/clm_203164BC0145.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 4,449,245,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_7D612B392881](/claim/clm_7D612B392881.md) | [clm_33C916697C43](/claim/clm_33C916697C43.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 895,522,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_DC0177CB2929](/claim/clm_DC0177CB2929.md) | [clm_AFF68BBC35BE](/claim/clm_AFF68BBC35BE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 4,860,427,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_246434942F91](/claim/clm_246434942F91.md) | [clm_CF6C0D5C4B30](/claim/clm_CF6C0D5C4B30.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 264,804,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_9B839ECAF179](/claim/clm_9B839ECAF179.md) | [clm_688F0D43862F](/claim/clm_688F0D43862F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000082/0001532176-16-000082-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 362,802,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_0981CA086973](/claim/clm_0981CA086973.md) | [clm_7149A1CA2203](/claim/clm_7149A1CA2203.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000082/0001532176-16-000082-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 543,047,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_47AF0CE8CA36](/claim/clm_47AF0CE8CA36.md) | [clm_B963E3479652](/claim/clm_B963E3479652.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000082/0001532176-16-000082-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 4,491,247,000 United States dollar | valid 2016-09-30 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_33C916697C43](/claim/clm_33C916697C43.md) | [clm_BD93EEA985A9](/claim/clm_BD93EEA985A9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000082/0001532176-16-000082-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,220,122,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_5AF2197029A2](/claim/clm_5AF2197029A2.md) | [clm_C7626FBBC9B4](/claim/clm_C7626FBBC9B4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000082/0001532176-16-000082-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 6,828,019,000 United States dollar | valid 2016-09-30 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_203164BC0145](/claim/clm_203164BC0145.md) | [clm_D5B8CC2A7197](/claim/clm_D5B8CC2A7197.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000082/0001532176-16-000082-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 920,359,000 United States dollar | valid 2016-09-30 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_06AB5E3637AD](/claim/clm_06AB5E3637AD.md) | [clm_DF775611DD53](/claim/clm_DF775611DD53.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000082/0001532176-16-000082-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 559,930,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_B963E3479652](/claim/clm_B963E3479652.md) | [clm_61FB221F52F9](/claim/clm_61FB221F52F9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000067/0001532176-16-000067-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,212,629,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_C7626FBBC9B4](/claim/clm_C7626FBBC9B4.md) | [clm_6B4AC1C07D2A](/claim/clm_6B4AC1C07D2A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000067/0001532176-16-000067-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 291,628,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_7149A1CA2203](/claim/clm_7149A1CA2203.md) | [clm_7203835AF9D6](/claim/clm_7203835AF9D6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000067/0001532176-16-000067-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 4,076,506,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_BD93EEA985A9](/claim/clm_BD93EEA985A9.md) | [clm_76A176931199](/claim/clm_76A176931199.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000067/0001532176-16-000067-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 646,508,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_DF775611DD53](/claim/clm_DF775611DD53.md) | [clm_7F0BA57185F7](/claim/clm_7F0BA57185F7.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000067/0001532176-16-000067-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 196,218,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_688F0D43862F](/claim/clm_688F0D43862F.md) | [clm_A69584A31BB4](/claim/clm_A69584A31BB4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000067/0001532176-16-000067-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 6,204,906,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_D5B8CC2A7197](/claim/clm_D5B8CC2A7197.md) | [clm_FFE019961773](/claim/clm_FFE019961773.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000067/0001532176-16-000067-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 604,214,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_7F0BA57185F7](/claim/clm_7F0BA57185F7.md) | [clm_0DC1B23A3E38](/claim/clm_0DC1B23A3E38.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000055/0001532176-16-000055-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 5,904,460,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_FFE019961773](/claim/clm_FFE019961773.md) | [clm_27428FFDF264](/claim/clm_27428FFDF264.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000055/0001532176-16-000055-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 329,308,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_7203835AF9D6](/claim/clm_7203835AF9D6.md) | [clm_6493D88744E3](/claim/clm_6493D88744E3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000055/0001532176-16-000055-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 3,765,082,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_76A176931199](/claim/clm_76A176931199.md) | [clm_6F441A6B882E](/claim/clm_6F441A6B882E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000055/0001532176-16-000055-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 470,112,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_61FB221F52F9](/claim/clm_61FB221F52F9.md) | [clm_82D4EB6D361F](/claim/clm_82D4EB6D361F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000055/0001532176-16-000055-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 165,736,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_A69584A31BB4](/claim/clm_A69584A31BB4.md) | [clm_8997B789C3CE](/claim/clm_8997B789C3CE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000055/0001532176-16-000055-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,200,849,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_6B4AC1C07D2A](/claim/clm_6B4AC1C07D2A.md) | [clm_A146DEFD4AD2](/claim/clm_A146DEFD4AD2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000055/0001532176-16-000055-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 636,056,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_AFF68BBC35BE](/claim/clm_AFF68BBC35BE.md) | [clm_65C9343FBB71](/claim/clm_65C9343FBB71.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 1,251,916,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_1B4689E225C8](/claim/clm_1B4689E225C8.md) | [clm_83526134FED4](/claim/clm_83526134FED4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 5,609,132,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_27428FFDF264](/claim/clm_27428FFDF264.md) | [clm_AE851A5E41A1](/claim/clm_AE851A5E41A1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 1,620,577,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_0710977E9941](/claim/clm_0710977E9941.md) | [clm_C192D950A63C](/claim/clm_C192D950A63C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 4,103,728,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_CF6C0D5C4B30](/claim/clm_CF6C0D5C4B30.md) | [clm_DA3C150446BB](/claim/clm_DA3C150446BB.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 809,102,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_0DC1B23A3E38](/claim/clm_0DC1B23A3E38.md) | [clm_E1A1DD321AA2](/claim/clm_E1A1DD321AA2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 3,654,837,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_6F441A6B882E](/claim/clm_6F441A6B882E.md) | [clm_E4E81E6E76BC](/claim/clm_E4E81E6E76BC.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,137,422,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_A146DEFD4AD2](/claim/clm_A146DEFD4AD2.md) | [clm_004FA2206A58](/claim/clm_004FA2206A58.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000037/0001532176-15-000037-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 392,422,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_6493D88744E3](/claim/clm_6493D88744E3.md) | [clm_013115790A9A](/claim/clm_013115790A9A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000037/0001532176-15-000037-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 654,587,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_E1A1DD321AA2](/claim/clm_E1A1DD321AA2.md) | [clm_9D0F451FC952](/claim/clm_9D0F451FC952.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000037/0001532176-15-000037-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 210,398,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_8997B789C3CE](/claim/clm_8997B789C3CE.md) | [clm_A492FAF0038B](/claim/clm_A492FAF0038B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000037/0001532176-15-000037-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 3,296,867,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_E4E81E6E76BC](/claim/clm_E4E81E6E76BC.md) | [clm_F47024193220](/claim/clm_F47024193220.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000037/0001532176-15-000037-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 425,924,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_82D4EB6D361F](/claim/clm_82D4EB6D361F.md) | [clm_FBAC011B1148](/claim/clm_FBAC011B1148.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000037/0001532176-15-000037-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 5,182,915,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_AE851A5E41A1](/claim/clm_AE851A5E41A1.md) | [clm_FC3EF79C19DA](/claim/clm_FC3EF79C19DA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000037/0001532176-15-000037-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 998,617,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_004FA2206A58](/claim/clm_004FA2206A58.md) | [clm_50CADC50AD04](/claim/clm_50CADC50AD04.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000029/0001532176-15-000029-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 194,643,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_A492FAF0038B](/claim/clm_A492FAF0038B.md) | [clm_596AA50FD9A5](/claim/clm_596AA50FD9A5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000029/0001532176-15-000029-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 344,859,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_013115790A9A](/claim/clm_013115790A9A.md) | [clm_5CB6EE7B0568](/claim/clm_5CB6EE7B0568.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000029/0001532176-15-000029-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 3,338,458,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_F47024193220](/claim/clm_F47024193220.md) | [clm_8F821934137F](/claim/clm_8F821934137F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000029/0001532176-15-000029-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 390,554,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_9D0F451FC952](/claim/clm_9D0F451FC952.md) | [clm_A572755A0D0E](/claim/clm_A572755A0D0E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000029/0001532176-15-000029-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 390,330,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_FBAC011B1148](/claim/clm_FBAC011B1148.md) | [clm_ECBF22AE9226](/claim/clm_ECBF22AE9226.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000029/0001532176-15-000029-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 4,526,970,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_FC3EF79C19DA](/claim/clm_FC3EF79C19DA.md) | [clm_F1F28102C74A](/claim/clm_F1F28102C74A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000029/0001532176-15-000029-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 283,553,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_5CB6EE7B0568](/claim/clm_5CB6EE7B0568.md) | [clm_0339E4418D85](/claim/clm_0339E4418D85.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000020/0001532176-15-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 507,907,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_A572755A0D0E](/claim/clm_A572755A0D0E.md) | [clm_1139EC91486A](/claim/clm_1139EC91486A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000020/0001532176-15-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 2,971,430,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_8F821934137F](/claim/clm_8F821934137F.md) | [clm_1AD620E8D1BF](/claim/clm_1AD620E8D1BF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000020/0001532176-15-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 869,612,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_50CADC50AD04](/claim/clm_50CADC50AD04.md) | [clm_34333BB2CA3F](/claim/clm_34333BB2CA3F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000020/0001532176-15-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 76,021,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_596AA50FD9A5](/claim/clm_596AA50FD9A5.md) | [clm_372DCD80253C](/claim/clm_372DCD80253C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000020/0001532176-15-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 343,113,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_ECBF22AE9226](/claim/clm_ECBF22AE9226.md) | [clm_8ACDB2D459CA](/claim/clm_8ACDB2D459CA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000020/0001532176-15-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 4,198,573,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_F1F28102C74A](/claim/clm_F1F28102C74A.md) | [clm_B102B1165213](/claim/clm_B102B1165213.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000020/0001532176-15-000020-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 648,719,000 United States dollar | valid 2014-12-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_1139EC91486A](/claim/clm_1139EC91486A.md) | [clm_6622B66FDA71](/claim/clm_6622B66FDA71.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000008/0001532176-15-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 2,819,557,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_DA3C150446BB](/claim/clm_DA3C150446BB.md) | [clm_81193541BA7F](/claim/clm_81193541BA7F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000008/0001532176-15-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 3,871,827,000 United States dollar | valid 2014-12-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_B102B1165213](/claim/clm_B102B1165213.md) | [clm_A1D3771334E7](/claim/clm_A1D3771334E7.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000008/0001532176-15-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 2,542,325,000 United States dollar | valid 2014-12-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_1AD620E8D1BF](/claim/clm_1AD620E8D1BF.md) | [clm_B9965B5284FE](/claim/clm_B9965B5284FE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000008/0001532176-15-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 838,431,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_83526134FED4](/claim/clm_83526134FED4.md) | [clm_BFC64F70A0E6](/claim/clm_BFC64F70A0E6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000008/0001532176-15-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 348,074,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_65C9343FBB71](/claim/clm_65C9343FBB71.md) | [clm_D3F5BB8C7757](/claim/clm_D3F5BB8C7757.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000008/0001532176-15-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 1,271,353,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_C192D950A63C](/claim/clm_C192D950A63C.md) | [clm_EFF482F34611](/claim/clm_EFF482F34611.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000008/0001532176-15-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 337,728,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_8ACDB2D459CA](/claim/clm_8ACDB2D459CA.md) | [clm_0EAC890E9792](/claim/clm_0EAC890E9792.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 646,554,000 United States dollar | valid 2014-09-30 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_6622B66FDA71](/claim/clm_6622B66FDA71.md) | [clm_579D4C297D5C](/claim/clm_579D4C297D5C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 2,551,788,000 United States dollar | valid 2014-09-30 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_B9965B5284FE](/claim/clm_B9965B5284FE.md) | [clm_5820D8A235B7](/claim/clm_5820D8A235B7.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 182,719,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_0339E4418D85](/claim/clm_0339E4418D85.md) | [clm_80E41A8C086F](/claim/clm_80E41A8C086F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 79,720,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_372DCD80253C](/claim/clm_372DCD80253C.md) | [clm_96E0C48FCE1B](/claim/clm_96E0C48FCE1B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 725,788,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_34333BB2CA3F](/claim/clm_34333BB2CA3F.md) | [clm_D15D4A6E6B04](/claim/clm_D15D4A6E6B04.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 3,739,419,000 United States dollar | valid 2014-09-30 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_A1D3771334E7](/claim/clm_A1D3771334E7.md) | [clm_E4D93A1F2B7B](/claim/clm_E4D93A1F2B7B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 294,501,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_0EAC890E9792](/claim/clm_0EAC890E9792.md) | [clm_3B3C62D2F90C](/claim/clm_3B3C62D2F90C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000035/0001532176-14-000035-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 665,700,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_D15D4A6E6B04](/claim/clm_D15D4A6E6B04.md) | [clm_3B9F3E529762](/claim/clm_3B9F3E529762.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000035/0001532176-14-000035-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 2,368,842,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_5820D8A235B7](/claim/clm_5820D8A235B7.md) | [clm_509A448302A2](/claim/clm_509A448302A2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000035/0001532176-14-000035-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 3,456,078,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_E4D93A1F2B7B](/claim/clm_E4D93A1F2B7B.md) | [clm_71FBC7380A33](/claim/clm_71FBC7380A33.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000035/0001532176-14-000035-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 600,135,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_579D4C297D5C](/claim/clm_579D4C297D5C.md) | [clm_878C5CCBECBD](/claim/clm_878C5CCBECBD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000035/0001532176-14-000035-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 92,735,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_96E0C48FCE1B](/claim/clm_96E0C48FCE1B.md) | [clm_D170703CFE06](/claim/clm_D170703CFE06.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000035/0001532176-14-000035-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 222,406,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_80E41A8C086F](/claim/clm_80E41A8C086F.md) | [clm_E091B4B6A620](/claim/clm_E091B4B6A620.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000035/0001532176-14-000035-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 65,443,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_D170703CFE06](/claim/clm_D170703CFE06.md) | [clm_241DC1271E83](/claim/clm_241DC1271E83.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000022/0001532176-14-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 287,379,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_3B3C62D2F90C](/claim/clm_3B3C62D2F90C.md) | [clm_298FEDBEF107](/claim/clm_298FEDBEF107.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000022/0001532176-14-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 2,211,248,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_509A448302A2](/claim/clm_509A448302A2.md) | [clm_60A1853443C7](/claim/clm_60A1853443C7.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000022/0001532176-14-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 625,740,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_3B9F3E529762](/claim/clm_3B9F3E529762.md) | [clm_6885E2367C01](/claim/clm_6885E2367C01.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000022/0001532176-14-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 461,858,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_878C5CCBECBD](/claim/clm_878C5CCBECBD.md) | [clm_6964C7D213F4](/claim/clm_6964C7D213F4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000022/0001532176-14-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 185,939,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_E091B4B6A620](/claim/clm_E091B4B6A620.md) | [clm_7C0F51D70380](/claim/clm_7C0F51D70380.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000022/0001532176-14-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 3,260,396,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_71FBC7380A33](/claim/clm_71FBC7380A33.md) | [clm_9B09C4FBCC86](/claim/clm_9B09C4FBCC86.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000022/0001532176-14-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 535,608,000 United States dollar | valid 2013-12-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_6964C7D213F4](/claim/clm_6964C7D213F4.md) | [clm_61B0FD9BE595](/claim/clm_61B0FD9BE595.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 760,028,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_BFC64F70A0E6](/claim/clm_BFC64F70A0E6.md) | [clm_8A99CD2AC1DF](/claim/clm_8A99CD2AC1DF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 424,362,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_D3F5BB8C7757](/claim/clm_D3F5BB8C7757.md) | [clm_945579B45ED0](/claim/clm_945579B45ED0.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 2,104,745,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_81193541BA7F](/claim/clm_81193541BA7F.md) | [clm_9AAE36CED876](/claim/clm_9AAE36CED876.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 2,951,013,000 United States dollar | valid 2013-12-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_9B09C4FBCC86](/claim/clm_9B09C4FBCC86.md) | [clm_9BF91030901D](/claim/clm_9BF91030901D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 859,947,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_EFF482F34611](/claim/clm_EFF482F34611.md) | [clm_D1E0932A289A](/claim/clm_D1E0932A289A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 1,952,076,000 United States dollar | valid 2013-12-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_60A1853443C7](/claim/clm_60A1853443C7.md) | [clm_D6EC6F37876A](/claim/clm_D6EC6F37876A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 224,045,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_298FEDBEF107](/claim/clm_298FEDBEF107.md) | [clm_33823C33ED82](/claim/clm_33823C33ED82.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000030/0001532176-13-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 236,802,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_7C0F51D70380](/claim/clm_7C0F51D70380.md) | [clm_57F54C76F7C4](/claim/clm_57F54C76F7C4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000030/0001532176-13-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 141,306,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_241DC1271E83](/claim/clm_241DC1271E83.md) | [clm_6400162ACAD1](/claim/clm_6400162ACAD1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000030/0001532176-13-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 2,640,415,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_9BF91030901D](/claim/clm_9BF91030901D.md) | [clm_81FEAF8A1B42](/claim/clm_81FEAF8A1B42.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000030/0001532176-13-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 263,211,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_61B0FD9BE595](/claim/clm_61B0FD9BE595.md) | [clm_ADF4E3F0D091](/claim/clm_ADF4E3F0D091.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000030/0001532176-13-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 1,690,171,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_D6EC6F37876A](/claim/clm_D6EC6F37876A.md) | [clm_CF49D665F1F6](/claim/clm_CF49D665F1F6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000030/0001532176-13-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 597,027,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_6885E2367C01](/claim/clm_6885E2367C01.md) | [clm_FFE707425BE2](/claim/clm_FFE707425BE2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000030/0001532176-13-000030-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 457,642,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_FFE707425BE2](/claim/clm_FFE707425BE2.md) | [clm_176F45465AD1](/claim/clm_176F45465AD1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000022/0001532176-13-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 87,376,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_6400162ACAD1](/claim/clm_6400162ACAD1.md) | [clm_501F214D494B](/claim/clm_501F214D494B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000022/0001532176-13-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 1,493,337,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_CF49D665F1F6](/claim/clm_CF49D665F1F6.md) | [clm_7E8E7F35A702](/claim/clm_7E8E7F35A702.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000022/0001532176-13-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 381,675,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_ADF4E3F0D091](/claim/clm_ADF4E3F0D091.md) | [clm_A67A80877FAD](/claim/clm_A67A80877FAD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000022/0001532176-13-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 187,463,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_33823C33ED82](/claim/clm_33823C33ED82.md) | [clm_B00FA7DE5A26](/claim/clm_B00FA7DE5A26.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000022/0001532176-13-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 2,378,259,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_81FEAF8A1B42](/claim/clm_81FEAF8A1B42.md) | [clm_E6470153188B](/claim/clm_E6470153188B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000022/0001532176-13-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 158,103,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_57F54C76F7C4](/claim/clm_57F54C76F7C4.md) | [clm_ED36DCD5E0B9](/claim/clm_ED36DCD5E0B9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000022/0001532176-13-000022-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 180,299,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_B00FA7DE5A26](/claim/clm_B00FA7DE5A26.md) | [clm_0523CCD853F5](/claim/clm_0523CCD853F5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000008/0001532176-13-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 153,050,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_ED36DCD5E0B9](/claim/clm_ED36DCD5E0B9.md) | [clm_2573AC111BC6](/claim/clm_2573AC111BC6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000008/0001532176-13-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 2,275,998,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_E6470153188B](/claim/clm_E6470153188B.md) | [clm_27AF6C1F02F9](/claim/clm_27AF6C1F02F9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000008/0001532176-13-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 439,664,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_176F45465AD1](/claim/clm_176F45465AD1.md) | [clm_3E5F56BC8504](/claim/clm_3E5F56BC8504.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000008/0001532176-13-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 180,362,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_A67A80877FAD](/claim/clm_A67A80877FAD.md) | [clm_5F5113D9E628](/claim/clm_5F5113D9E628.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000008/0001532176-13-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 98,874,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_501F214D494B](/claim/clm_501F214D494B.md) | [clm_62038DF4A8A1](/claim/clm_62038DF4A8A1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000008/0001532176-13-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 1,406,348,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_7E8E7F35A702](/claim/clm_7E8E7F35A702.md) | [clm_E05AB5ED8875](/claim/clm_E05AB5ED8875.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000008/0001532176-13-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 1,378,477,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_9AAE36CED876](/claim/clm_9AAE36CED876.md) | [clm_0B45DD87AE68](/claim/clm_0B45DD87AE68.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000004/0001532176-13-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 625,554,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_D1E0932A289A](/claim/clm_D1E0932A289A.md) | [clm_1BAC3F81B511](/claim/clm_1BAC3F81B511.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000004/0001532176-13-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 230,276,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_5F5113D9E628](/claim/clm_5F5113D9E628.md) | [clm_1E166CBF8C7E](/claim/clm_1E166CBF8C7E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000004/0001532176-13-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 750,269,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_945579B45ED0](/claim/clm_945579B45ED0.md) | [clm_2F265702ECB5](/claim/clm_2F265702ECB5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000004/0001532176-13-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 457,713,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_8A99CD2AC1DF](/claim/clm_8A99CD2AC1DF.md) | [clm_38E3B92F967E](/claim/clm_38E3B92F967E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000004/0001532176-13-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 2,080,490,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_27AF6C1F02F9](/claim/clm_27AF6C1F02F9.md) | [clm_A372EDBC91D9](/claim/clm_A372EDBC91D9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000004/0001532176-13-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 1,245,385,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_E05AB5ED8875](/claim/clm_E05AB5ED8875.md) | [clm_B3960C0B2099](/claim/clm_B3960C0B2099.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000004/0001532176-13-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 806,024,000 United States dollar | valid 2012-09-30 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_B3960C0B2099](/claim/clm_B3960C0B2099.md) | [clm_1DFB726EC635](/claim/clm_1DFB726EC635.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217612000004/0001532176-12-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 118,998,000 United States dollar | valid 2012-09-30 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_1E166CBF8C7E](/claim/clm_1E166CBF8C7E.md) | [clm_6A776163AAFA](/claim/clm_6A776163AAFA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217612000004/0001532176-12-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 427,687,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_3E5F56BC8504](/claim/clm_3E5F56BC8504.md) | [clm_82AF3B3F2E9E](/claim/clm_82AF3B3F2E9E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217612000004/0001532176-12-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 1,660,615,000 United States dollar | valid 2012-09-30 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_A372EDBC91D9](/claim/clm_A372EDBC91D9.md) | [clm_8DFDB982480A](/claim/clm_8DFDB982480A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217612000004/0001532176-12-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 202,364,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_2573AC111BC6](/claim/clm_2573AC111BC6.md) | [clm_9ECACDE79861](/claim/clm_9ECACDE79861.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217612000004/0001532176-12-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 191,468,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_62038DF4A8A1](/claim/clm_62038DF4A8A1.md) | [clm_B873B34DF388](/claim/clm_B873B34DF388.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217612000004/0001532176-12-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 158,295,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_0523CCD853F5](/claim/clm_0523CCD853F5.md) | [clm_E00C8F83DE93](/claim/clm_E00C8F83DE93.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217612000004/0001532176-12-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 93,955,110 shares | valid 2012-07-13 to present | conf 0.95 | valid | [clm_24C3500A1DEF](/claim/clm_24C3500A1DEF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 147,373,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_E00C8F83DE93](/claim/clm_E00C8F83DE93.md) | [clm_1557BB809F3B](/claim/clm_1557BB809F3B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 171,943,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_6A776163AAFA](/claim/clm_6A776163AAFA.md) | [clm_511459233BCE](/claim/clm_511459233BCE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 594,657,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_1DFB726EC635](/claim/clm_1DFB726EC635.md) | [clm_9E8EECD34DB3](/claim/clm_9E8EECD34DB3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 1,457,500,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_8DFDB982480A](/claim/clm_8DFDB982480A.md) | [clm_A3017E7DE44C](/claim/clm_A3017E7DE44C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 87,478,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_9ECACDE79861](/claim/clm_9ECACDE79861.md) | [clm_C01BAE2ED355](/claim/clm_C01BAE2ED355.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 76,743,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_B873B34DF388](/claim/clm_B873B34DF388.md) | [clm_C602747CFC82](/claim/clm_C602747CFC82.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 304,399,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_82AF3B3F2E9E](/claim/clm_82AF3B3F2E9E.md) | [clm_F838E1612E57](/claim/clm_F838E1612E57.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 93,032,889 shares | valid 2012-04-11 to 2012-07-13 | conf 0.95 | superseded | superseded_by [clm_24C3500A1DEF](/claim/clm_24C3500A1DEF.md) | [clm_577DFD723982](/claim/clm_577DFD723982.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 394,585,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_511459233BCE](/claim/clm_511459233BCE.md) | [clm_887DBFDB9082](/claim/clm_887DBFDB9082.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 1,350,159,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_A3017E7DE44C](/claim/clm_A3017E7DE44C.md) | [clm_ADE56CD2A2B3](/claim/clm_ADE56CD2A2B3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 231,789,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_F838E1612E57](/claim/clm_F838E1612E57.md) | [clm_C5D81A308356](/claim/clm_C5D81A308356.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 22,201,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_C01BAE2ED355](/claim/clm_C01BAE2ED355.md) | [clm_C93221C62CF4](/claim/clm_C93221C62CF4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 504,024,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_9E8EECD34DB3](/claim/clm_9E8EECD34DB3.md) | [clm_DBC9DBB0188D](/claim/clm_DBC9DBB0188D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 11,651,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_C602747CFC82](/claim/clm_C602747CFC82.md) | [clm_DE7CE27F0752](/claim/clm_DE7CE27F0752.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 138,862,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_1557BB809F3B](/claim/clm_1557BB809F3B.md) | [clm_F56438C2065F](/claim/clm_F56438C2065F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 91,779,465 shares | valid 2012-02-10 to 2012-04-11 | conf 0.95 | superseded | superseded_by [clm_577DFD723982](/claim/clm_577DFD723982.md) | [clm_CC510D3CC49D](/claim/clm_CC510D3CC49D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 445,824,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_0B45DD87AE68](/claim/clm_0B45DD87AE68.md) | [clm_32D9C9A4307F](/claim/clm_32D9C9A4307F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 1,323,583,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_ADE56CD2A2B3](/claim/clm_ADE56CD2A2B3.md) | [clm_545A6A3B5E05](/claim/clm_545A6A3B5E05.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 485,732,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_DBC9DBB0188D](/claim/clm_DBC9DBB0188D.md) | [clm_589084C462D0](/claim/clm_589084C462D0.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 529,506,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_1BAC3F81B511](/claim/clm_1BAC3F81B511.md) | [clm_9C8A4A104B4F](/claim/clm_9C8A4A104B4F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 483,610,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_887DBFDB9082](/claim/clm_887DBFDB9082.md) | [clm_C5F7ECAA4C25](/claim/clm_C5F7ECAA4C25.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | -205,159,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_38E3B92F967E](/claim/clm_38E3B92F967E.md) | [clm_E89A362E23D2](/claim/clm_E89A362E23D2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | -221,760,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_2F265702ECB5](/claim/clm_2F265702ECB5.md) | [clm_F3AAA9683DBE](/claim/clm_F3AAA9683DBE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 90,466,178 shares | valid 2011-10-19 to 2012-02-10 | conf 0.95 | superseded | superseded_by [clm_CC510D3CC49D](/claim/clm_CC510D3CC49D.md) | [clm_1AE57BD8CE95](/claim/clm_1AE57BD8CE95.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 428,253,000 United States dollar | valid 2011-09-30 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_589084C462D0](/claim/clm_589084C462D0.md) | [clm_1330872EE468](/claim/clm_1330872EE468.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 983,031,000 United States dollar | valid 2011-09-30 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_545A6A3B5E05](/claim/clm_545A6A3B5E05.md) | [clm_377708CC6732](/claim/clm_377708CC6732.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | -58,457,000 United States dollar | valid 2011-09-30 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_C93221C62CF4](/claim/clm_C93221C62CF4.md) | [clm_3B9F0AEC9660](/claim/clm_3B9F0AEC9660.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 206,395,000 United States dollar | valid 2011-09-30 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_C5F7ECAA4C25](/claim/clm_C5F7ECAA4C25.md) | [clm_8F646FBC58B0](/claim/clm_8F646FBC58B0.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 127,924,000 United States dollar | valid 2011-09-30 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_F56438C2065F](/claim/clm_F56438C2065F.md) | [clm_D248A8950FA4](/claim/clm_D248A8950FA4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 102,833,000 United States dollar | valid 2011-09-30 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_C5D81A308356](/claim/clm_C5D81A308356.md) | [clm_EC0E16DDB2D8](/claim/clm_EC0E16DDB2D8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -62,365,000 United States dollar | valid 2011-09-30 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_DE7CE27F0752](/claim/clm_DE7CE27F0752.md) | [clm_FBBAE356E784](/claim/clm_FBBAE356E784.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 89,499,900 shares | valid 2011-07-15 to 2011-10-19 | conf 0.95 | superseded | superseded_by [clm_1AE57BD8CE95](/claim/clm_1AE57BD8CE95.md) | [clm_EAEA070624D5](/claim/clm_EAEA070624D5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 143,149,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_D248A8950FA4](/claim/clm_D248A8950FA4.md) | [clm_0F6159727C59](/claim/clm_0F6159727C59.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 1,046,864,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_377708CC6732](/claim/clm_377708CC6732.md) | [clm_34A57EEA9DE6](/claim/clm_34A57EEA9DE6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 478,034,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_1330872EE468](/claim/clm_1330872EE468.md) | [clm_510855B8D0BD](/claim/clm_510855B8D0BD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | -60,319,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_3B9F0AEC9660](/claim/clm_3B9F0AEC9660.md) | [clm_5DD062633A03](/claim/clm_5DD062633A03.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 254,312,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_8F646FBC58B0](/claim/clm_8F646FBC58B0.md) | [clm_6BA60CDC0B9D](/claim/clm_6BA60CDC0B9D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 107,810,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_EC0E16DDB2D8](/claim/clm_EC0E16DDB2D8.md) | [clm_A35410AC229A](/claim/clm_A35410AC229A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -62,505,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_FBBAE356E784](/claim/clm_FBBAE356E784.md) | [clm_BEE2EE1A4F91](/claim/clm_BEE2EE1A4F91.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 88,739,294 shares | valid 2011-04-13 to 2011-07-15 | conf 0.95 | superseded | superseded_by [clm_EAEA070624D5](/claim/clm_EAEA070624D5.md) | [clm_4A8E4990BE56](/claim/clm_4A8E4990BE56.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 1,074,293,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_34A57EEA9DE6](/claim/clm_34A57EEA9DE6.md) | [clm_041DF9FBC553](/claim/clm_041DF9FBC553.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | -40,981,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_5DD062633A03](/claim/clm_5DD062633A03.md) | [clm_12E93F04613F](/claim/clm_12E93F04613F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 129,392,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_0F6159727C59](/claim/clm_0F6159727C59.md) | [clm_371C6065B00F](/claim/clm_371C6065B00F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 112,204,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_A35410AC229A](/claim/clm_A35410AC229A.md) | [clm_6475C30104FE](/claim/clm_6475C30104FE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 135,376,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_6BA60CDC0B9D](/claim/clm_6BA60CDC0B9D.md) | [clm_9135C6B074D1](/claim/clm_9135C6B074D1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 518,091,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_510855B8D0BD](/claim/clm_510855B8D0BD.md) | [clm_91765377ED79](/claim/clm_91765377ED79.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -43,447,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_BEE2EE1A4F91](/claim/clm_BEE2EE1A4F91.md) | [clm_EBB8DD46F73B](/claim/clm_EBB8DD46F73B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 87,777,008 shares | valid 2011-02-11 to 2011-04-13 | conf 0.95 | superseded | superseded_by [clm_4A8E4990BE56](/claim/clm_4A8E4990BE56.md) | [clm_9F1578405220](/claim/clm_9F1578405220.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | -97,472,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_E89A362E23D2](/claim/clm_E89A362E23D2.md) | [clm_244D0F6FC089](/claim/clm_244D0F6FC089.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 112,572,000 United States dollar | valid 2010-12-31 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_9135C6B074D1](/claim/clm_9135C6B074D1.md) | [clm_25FEBCAE80F4](/claim/clm_25FEBCAE80F4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 1,089,432,000 United States dollar | valid 2010-12-31 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_041DF9FBC553](/claim/clm_041DF9FBC553.md) | [clm_29EB7E3E7FF4](/claim/clm_29EB7E3E7FF4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 527,815,000 United States dollar | valid 2010-12-31 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_91765377ED79](/claim/clm_91765377ED79.md) | [clm_5007EE5455F4](/claim/clm_5007EE5455F4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | -104,468,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_F3AAA9683DBE](/claim/clm_F3AAA9683DBE.md) | [clm_9855FD3A29B1](/claim/clm_9855FD3A29B1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 459,074,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_32D9C9A4307F](/claim/clm_32D9C9A4307F.md) | [clm_9A959E160676](/claim/clm_9A959E160676.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 489,252,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_9C8A4A104B4F](/claim/clm_9C8A4A104B4F.md) | [clm_DBA4D7F8FE2B](/claim/clm_DBA4D7F8FE2B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 80,111,128 shares | valid 2010-10-15 to 2011-02-11 | conf 0.95 | superseded | superseded_by [clm_9F1578405220](/claim/clm_9F1578405220.md) | [clm_8E21F9F74138](/claim/clm_8E21F9F74138.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -33,875,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_EBB8DD46F73B](/claim/clm_EBB8DD46F73B.md) | [clm_28ABCB90078C](/claim/clm_28ABCB90078C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 942,433,000 United States dollar | valid 2010-09-30 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_29EB7E3E7FF4](/claim/clm_29EB7E3E7FF4.md) | [clm_48CC933138DD](/claim/clm_48CC933138DD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 348,064,000 United States dollar | valid 2010-09-30 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_5007EE5455F4](/claim/clm_5007EE5455F4.md) | [clm_64A26E8ED78A](/claim/clm_64A26E8ED78A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 325,286,000 United States dollar | valid 2010-09-30 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_25FEBCAE80F4](/claim/clm_25FEBCAE80F4.md) | [clm_B61AEABD9233](/claim/clm_B61AEABD9233.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | -32,094,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_12E93F04613F](/claim/clm_12E93F04613F.md) | [clm_BA0DB10F3D70](/claim/clm_BA0DB10F3D70.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 122,043,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_371C6065B00F](/claim/clm_371C6065B00F.md) | [clm_C839FB986331](/claim/clm_C839FB986331.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 105,979,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_6475C30104FE](/claim/clm_6475C30104FE.md) | [clm_E85633B203A9](/claim/clm_E85633B203A9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | shares_outstanding | 79,931,305 shares | valid 2010-07-15 to 2010-10-15 | conf 0.95 | superseded | superseded_by [clm_8E21F9F74138](/claim/clm_8E21F9F74138.md) | [clm_34FD3B78CE3A](/claim/clm_34FD3B78CE3A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | -23,724,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_BA0DB10F3D70](/claim/clm_BA0DB10F3D70.md) | [clm_4766DAD2B8E4](/claim/clm_4766DAD2B8E4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 124,526,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_C839FB986331](/claim/clm_C839FB986331.md) | [clm_50D037B8E10B](/claim/clm_50D037B8E10B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -25,474,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_28ABCB90078C](/claim/clm_28ABCB90078C.md) | [clm_620FABA54C3D](/claim/clm_620FABA54C3D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 115,886,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_E85633B203A9](/claim/clm_E85633B203A9.md) | [clm_627655F53872](/claim/clm_627655F53872.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 112,000,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_B61AEABD9233](/claim/clm_B61AEABD9233.md) | [clm_BBF34107EC0B](/claim/clm_BBF34107EC0B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 790,641,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_48CC933138DD](/claim/clm_48CC933138DD.md) | [clm_BD65B570A4E4](/claim/clm_BD65B570A4E4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 371,216,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_64A26E8ED78A](/claim/clm_64A26E8ED78A.md) | [clm_E4A47C6EE8A9](/claim/clm_E4A47C6EE8A9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 117,311,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_BBF34107EC0B](/claim/clm_BBF34107EC0B.md) | [clm_078E98AC1ADB](/claim/clm_078E98AC1ADB.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -30,522,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_620FABA54C3D](/claim/clm_620FABA54C3D.md) | [clm_7AF7234E1826](/claim/clm_7AF7234E1826.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | -28,877,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_4766DAD2B8E4](/claim/clm_4766DAD2B8E4.md) | [clm_802C2C55FF06](/claim/clm_802C2C55FF06.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 117,471,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_50D037B8E10B](/claim/clm_50D037B8E10B.md) | [clm_B517328AE72E](/claim/clm_B517328AE72E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 103,534,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_627655F53872](/claim/clm_627655F53872.md) | [clm_C140F465B911](/claim/clm_C140F465B911.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 386,271,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_E4A47C6EE8A9](/claim/clm_E4A47C6EE8A9.md) | [clm_CBE9497E634B](/claim/clm_CBE9497E634B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | -67,830,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_9855FD3A29B1](/claim/clm_9855FD3A29B1.md) | [clm_4BD3F29C30C3](/claim/clm_4BD3F29C30C3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 207,075,000 United States dollar | valid 2009-12-31 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_078E98AC1ADB](/claim/clm_078E98AC1ADB.md) | [clm_627E980C26AD](/claim/clm_627E980C26AD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 741,202,000 United States dollar | valid 2009-12-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_BD65B570A4E4](/claim/clm_BD65B570A4E4.md) | [clm_6561AF99BE78](/claim/clm_6561AF99BE78.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 398,762,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_DBA4D7F8FE2B](/claim/clm_DBA4D7F8FE2B.md) | [clm_8BB3624F55A2](/claim/clm_8BB3624F55A2.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 396,762,000 United States dollar | valid 2009-12-31 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_CBE9497E634B](/claim/clm_CBE9497E634B.md) | [clm_C14FC9DD9C3D](/claim/clm_C14FC9DD9C3D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | -74,103,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_244D0F6FC089](/claim/clm_244D0F6FC089.md) | [clm_C6F910B9B23D](/claim/clm_C6F910B9B23D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 379,268,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_9A959E160676](/claim/clm_9A959E160676.md) | [clm_F4AAD27D2977](/claim/clm_F4AAD27D2977.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 117,455,000 United States dollar | valid 2009-09-30 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_C140F465B911](/claim/clm_C140F465B911.md) | [clm_180A6BFB73AB](/claim/clm_180A6BFB73AB.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | -1,291,000 United States dollar | valid 2009-09-30 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_802C2C55FF06](/claim/clm_802C2C55FF06.md) | [clm_1C4BAC822C1D](/claim/clm_1C4BAC822C1D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 422,443,000 United States dollar | valid 2009-09-30 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_C14FC9DD9C3D](/claim/clm_C14FC9DD9C3D.md) | [clm_1E23E8E53794](/claim/clm_1E23E8E53794.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 250,321,000 United States dollar | valid 2009-09-30 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_627E980C26AD](/claim/clm_627E980C26AD.md) | [clm_7918862037C1](/claim/clm_7918862037C1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -1,015,000 United States dollar | valid 2009-09-30 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_7AF7234E1826](/claim/clm_7AF7234E1826.md) | [clm_AFED42FED572](/claim/clm_AFED42FED572.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 105,434,000 United States dollar | valid 2009-09-30 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_B517328AE72E](/claim/clm_B517328AE72E.md) | [clm_BF74EFFD510C](/claim/clm_BF74EFFD510C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 90,032,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_180A6BFB73AB](/claim/clm_180A6BFB73AB.md) | [clm_8F23955A5DC1](/claim/clm_8F23955A5DC1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 94,231,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_BF74EFFD510C](/claim/clm_BF74EFFD510C.md) | [clm_929B1DC18D5F](/claim/clm_929B1DC18D5F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | -16,266,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_1C4BAC822C1D](/claim/clm_1C4BAC822C1D.md) | [clm_B2E1F9844DD6](/claim/clm_B2E1F9844DD6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 271,466,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_7918862037C1](/claim/clm_7918862037C1.md) | [clm_BA6D5CDEA514](/claim/clm_BA6D5CDEA514.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 410,506,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_1E23E8E53794](/claim/clm_1E23E8E53794.md) | [clm_C2FCE96BEF20](/claim/clm_C2FCE96BEF20.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -14,938,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_AFED42FED572](/claim/clm_AFED42FED572.md) | [clm_FE7982325BDD](/claim/clm_FE7982325BDD.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 421,514,000 United States dollar | valid 2008-12-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_C2FCE96BEF20](/claim/clm_C2FCE96BEF20.md) | [clm_27270E64C661](/claim/clm_27270E64C661.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | -86,249,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_C6F910B9B23D](/claim/clm_C6F910B9B23D.md) | [clm_3E8FF1B94F70](/claim/clm_3E8FF1B94F70.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | -79,129,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_4BD3F29C30C3](/claim/clm_4BD3F29C30C3.md) | [clm_7DFF0FB9DC16](/claim/clm_7DFF0FB9DC16.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 274,903,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_8BB3624F55A2](/claim/clm_8BB3624F55A2.md) | [clm_9548E82DE9F9](/claim/clm_9548E82DE9F9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 238,457,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_F4AAD27D2977](/claim/clm_F4AAD27D2977.md) | [clm_BC2C8A20F65B](/claim/clm_BC2C8A20F65B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 247,796,000 United States dollar | valid 2008-12-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_BA6D5CDEA514](/claim/clm_BA6D5CDEA514.md) | [clm_BC8073BF4473](/claim/clm_BC8073BF4473.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 498,925,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_BC8073BF4473](/claim/clm_BC8073BF4473.md) | [clm_E2D362DD631E](/claim/clm_E2D362DD631E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 459,348,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_27270E64C661](/claim/clm_27270E64C661.md) | [clm_E47A2EAF4706](/claim/clm_E47A2EAF4706.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | registrant_name | REGENERON PHARMACEUTICALS, INC. | valid 1995-07-26 to present | conf 0.95 | valid | [clm_0230630DE966](/claim/clm_0230630DE966.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | ceo | Leonard S. Schleifer | valid 1988-01-01 to present | conf 0.95 | valid | [clm_31DC6D4DC56C](/claim/clm_31DC6D4DC56C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cik | 0000872589 | valid undated to present | conf 0.95 | valid | [clm_0D4E584017A3](/claim/clm_0D4E584017A3.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | fiscal_year_end | 12-31 | valid undated to present | conf 0.95 | valid | [clm_2BC841F0E994](/claim/clm_2BC841F0E994.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | state_of_incorporation | NY | valid undated to present | conf 0.95 | valid | [clm_2EE7611EC44C](/claim/clm_2EE7611EC44C.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | headquarters | Tarrytown | valid undated to present | conf 0.95 | valid | [clm_4EBDB058F389](/claim/clm_4EBDB058F389.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | listed_on | Nasdaq | valid undated to present | conf 0.95 | valid | [clm_60E05C2B8B5C](/claim/clm_60E05C2B8B5C.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | sic_industry | Pharmaceutical Preparations (2834) | valid undated to present | conf 0.95 | valid | [clm_BAC78AB8CD88](/claim/clm_BAC78AB8CD88.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | ticker | REGN | valid undated to present | conf 0.95 | valid | [clm_CE8DC6176B9E](/claim/clm_CE8DC6176B9E.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589 --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.